Clinical Trial

Role of Programmed Death Ligand 1 in Colorectal Cancer

Name: Role of Programmed Death Ligand 1 in Colorectal Cancer — clinical trial record (NCT07088341)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SPDL1

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

1. \- Evaluation of diagnostic importance of soluble programmed death ligand-1 in patient with recently diagnosed as Colorectal cancer at different stages of disease . 2. Correlation of SPDL-1 level and clinco-pathological data of patients at presentation .

Trial Details

NCT Number	NCT07088341
Lead Sponsor	Assiut University
Conditions	Colo-rectal Cancer
Enrollment	90 participants
Start Date	2025-08-01
Primary Completion	2026-08-30 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-28